Pluri Inc. financial data

Symbol
PLUR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Matam Advanced Technology Park, Building No. 5, Haifa, Israel
State of incorporation
NV
Fiscal year end
June 30
Former names
PLURISTEM THERAPEUTICS INC (to 7/13/2022), PLURISTEM LIFE SYSTEMS INC (to 12/28/2007), AI SOFTWARE INC (to 7/1/2003)
Latest financial report
10-K - Q2 2024 - Sep 18, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 707 % -19.9%
Return On Equity -335 % -161%
Return On Assets -51.6 % -3.2%
Operating Margin -6.8K % +28.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.47M shares -86.8%
Common Stock, Shares, Outstanding 5.41M shares +4.9%
Entity Public Float 22.9M USD -33.6%
Weighted Average Number of Shares Outstanding, Basic 5.24M shares +14.4%
Weighted Average Number of Shares Outstanding, Diluted 5.24M shares +14.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 326K USD +13.6%
Research and Development Expense 12.4M USD -21%
General and Administrative Expense 10M USD -14.8%
Operating Income (Loss) -22.2M USD +18.7%
Nonoperating Income (Expense) 814K USD
Net Income (Loss) Attributable to Parent -20.9M USD +26.2%
Earnings Per Share, Basic -3.99 USD/shares +36.1%
Earnings Per Share, Diluted -3.99 USD/shares +36.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.78M USD +26.5%
Cash, Cash Equivalents, and Short-term Investments 30.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3K USD -84.2%
Assets, Current 31.1M USD -24.9%
Property, Plant and Equipment, Net 688K USD 0%
Operating Lease, Right-of-Use Asset 6.56M USD -14.1%
Other Assets, Noncurrent 70K USD +6900%
Assets 39.5M USD -22.2%
Employee-related Liabilities, Current 508K USD -18.6%
Accrued Liabilities, Current 1.22M USD +1.16%
Liabilities, Current 4.45M USD -20.8%
Operating Lease, Liability, Noncurrent 5.03M USD -12.6%
Retained Earnings (Accumulated Deficit) -420M USD -5.23%
Stockholders' Equity Attributable to Parent 96K USD -99.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.42M USD -64.6%
Liabilities and Equity 39.5M USD -22.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.86M USD +23%
Net Cash Provided by (Used in) Investing Activities 5.8M USD -9.24%
Common Stock, Shares Authorized 37.5M shares 0%
Common Stock, Shares, Issued 5.41M shares +4.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -97K USD +93%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.67M USD +22.6%
Deferred Tax Assets, Valuation Allowance 73.8M USD -13%
Deferred Tax Assets, Gross 71.3M USD +11.5%
Operating Lease, Liability 5.59M USD -12.4%
Depreciation 67K USD -33%
Payments to Acquire Property, Plant, and Equipment 103K USD +41.1%
Lessee, Operating Lease, Liability, to be Paid 7.71M USD -14.1%
Property, Plant and Equipment, Gross 18.4M USD +1.4%
Operating Lease, Liability, Current 559K USD -10.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.01M USD -9.49%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.11M USD -4.46%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.12M USD -18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 977K USD -3.84%
Deferred Tax Assets, Operating Loss Carryforwards 69.9M USD -13.3%
Preferred Stock, Shares Authorized 1M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.02M USD +3.02%
Additional Paid in Capital 421M USD +1.85%
Deferred Tax Assets, Net of Valuation Allowance 73.8M USD -13%
Share-based Payment Arrangement, Expense 170K USD -17.1%
Interest Expense 868K USD +0.46%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares